莎普爱思: 莎普爱思股东集中竞价减持股份结果公告

Summary of Key Points Core Viewpoint - The announcement details the results of a share reduction plan executed by Shanghai Jingxing Industrial Investment Co., Ltd., a shareholder of Zhejiang Shapuaisi Pharmaceutical Co., Ltd., indicating a significant decrease in shareholding through a concentrated bidding process. Shareholder Holding Situation - As of March 18, 2025, Shanghai Jingxing held 16,150,426 shares, representing 4.2962% of Shapuaisi's total share capital [1] - The shareholder is not a controlling shareholder or a significant shareholder with over 5% ownership [1] Implementation of Reduction Plan - The reduction plan was executed from March 21, 2025, to June 20, 2025, during which Shanghai Jingxing reduced its holdings by 3,167,700 shares [1] - As of June 20, 2025, the remaining shares held by Shanghai Jingxing amounted to 12,982,726, which is 3.4535% of the total shares [1] Reduction Details - The shares were sold at a price range of 7.28 to 7.84 yuan per share, totaling a reduction amount of 23,377,456.72 yuan [1] - The actual reduction represented 0.8426% of the total shares, which is below the originally planned maximum reduction of 3% [1] Compliance with Reduction Plan - The actual reduction was consistent with the previously disclosed reduction plan, and the plan was fully executed within the specified timeframe [2]